eMolecules, Inc., provider of the industry-leading chemical compound search-and-fulfillment platform for early discovery chemistry research, announces that it has acquired Synple Chem AG (“Synple”). Synple specializes in automated chemical synthesis systems and solutions for small molecules drug discovery customers. With Snyple’s virtual compound library, which provides access to more than 7 trillion tractable compounds, combined with eMolecules’ eXplore library of more than 4 trillion compounds, eMolecules now offers the world’s most diverse selection of virtual compounds.
Read the full article: eMolecules Acquires Synple Chem AG //
Source: https://www.prnewswire.com/news-releases/emolecules-acquires-synple-chem-ag-302256279.html